All Stories

  1. Tourette syndrome research highlights from 2022
  2. Door-To-Door Video-Enhanced Prevalence Study of Tourette Disorder Among African Americans
  3. Smoke gets in your tics
  4. Study protocol: A cross-sectional survey of clinicians to identify barriers to clinical practice guideline implementation in the assessment and treatment of persistent tic disorders
  5. Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial
  6. Early‐Life and Family Risk Factors for Tic Disorder Persistence into Adulthood
  7. Tics in ADHD
  8. Finding reviewer suggestions for multi-author papers
  9. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  10. Editorial: Recent advances in understanding Tourette syndrome, tic disorders and functional tics
  11. Smoke gets in your tics
  12. Will people buzz their wrist in their daily life to help their tics?
  13. Testing whether median nerve stimulation helps tics by the mechanism we thought it did
  14. Tics in ADHD
  15. Suggestions for new NIH grant applicants
  16. Peripheral nerve induction of inhibitory brain circuits to treat Tourette syndrome: A randomized crossover trial
  17. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  18. TikTok Tourette’s: Are We Witnessing a Rise in Functional Tic-Like Behavior Driven by Adolescent Social Media Use?
  19. Tic prevalence by direct observation in an elementary school
  20. Tourette syndrome research highlights from 2021
  21. Diagnosis and Management of Functional Tic-Like Phenomena
  22. Door-to-door Video-Enhanced Prevalence Study of Tourette Disorder Among African Americans
  23. Why Tic Severity Changes from Then to Now and from Here to There
  24. Functional tic-like presentations differ strikingly from Provisional Tic Disorder
  25. Median nerve stimulation for treatment of tics: A 4-week, open trial with ecological momentary assessment
  26. TikTok Tourette's: are we witnessing a rise in neurological conditions driven by adolescent social media use?
  27. Why tic severity changes from then to now and from here to there
  28. The start of the biggest brain imaging and genetics study ever in Tourette syndrome
  29. Finding reviewer suggestions for multi-author papers
  30. Optimal timing for lithium levels
  31. Tourette syndrome research highlights from 2021
  32. Tourette syndrome research highlights from 2020
  33. Neurobiology and Functional Anatomy of Tic Disorders
  34. The timing of tics is fractal, even in the first few months of a tic disorder
  35. Tourette syndrome research highlights from 2020
  36. Treatment failure in persistent tic disorders: an expert clinicians’ consensus-based definition
  37. Predicting Clinical Course from Subcortical Shape in Provisional Tic Disorder
  38. Low-Dose Augmentation With Buprenorphine for Treatment-Resistant Depression: A Multisite Randomized Controlled Trial With Multimodal Assessment of Target Engagement
  39. Recent progress on Tourette syndrome
  40. A Comprehensive Review of Tic Disorders in Children
  41. What happens to tic disorders over time?
  42. "I can hold my tics back for a while. What does that tell me?"
  43. TicTimer Web: software for measuring tic suppression remotely
  44. Electronic medical records need to accommodate confidentiality for presymptomatic testing
  45. The Child with Tics or Other Common Movement Disorders
  46. Tourette syndrome research highlights from 2019
  47. Course of tic disorders over the lifespan
  48. Tourette syndrome research highlights from 2019
  49. TicTimer Web: software for measuring tic suppression remotely
  50. Correlates and clinical implications of tic suppressibility
  51. Size of hippocampus predicts improvement in children with recent-onset tics
  52. Phonic tics and one motor tic? Call it Tourette syndrome.
  53. Can we measure Parkinson disease severity with levodopa and MRI?
  54. In obesity, pictures of high-calorie food elicit dopamine release equally when hungry or full.
  55. Hippocampal volume in Provisional Tic Disorder predicts tic severity at 12-month follow-up
  56. What happens to children with recent-onset tics, and why?
  57. Dopamine buffering capacity imaging: A pharmacodynamic fMRI method for staging Parkinson disease
  58. 2.54 EXPLORING BEHAVIORAL MARKERS PREDICTING ONE-YEAR TIC OUTCOME IN CHILDREN WITH RECENT-ONSET TICS
  59. Treating depression in epilepsy: a controlled trial
  60. The urge to blink in Tourette syndrome
  61. Tourette syndrome research highlights from 2018
  62. Atypical Functional Connectivity In Tourette Syndrome differs between Children and Adults
  63. Tic Suppression in Children With Recent-Onset Tics Predicts 1-Year Tic Outcome
  64. In Provisional Tic Disorder, better tic suppression predicts better prognosis
  65. Provisional Tic Disorder is not so transient
  66. Ziprasidone may have a role in treating psychosis in Parkinsonian disease
  67. The urge to blink in Tourette syndrome
  68. How to switch to pimavanserin from an older antipsychotic for psychosis in Parkinson's disease
  69. Transient tics aren't: Outcome of recent-onset tic disorder at one year
  70. Testing a new (D1) dopamine blocking strategy to treat Tourette syndrome in children
  71. TicTrainer software
  72. Research on tic disorders from 2017
  73. Effects of DBS in dorsal vs. ventral STN
  74. Who can suppress tics best?
  75. TicTimer software for measuring tic suppression
  76. TicTrainer web software for tic suppression training
  77. Tourette syndrome research highlights from 2016
  78. Patterns and predictors of tic suppressibility in youth with tic disorders
  79. TicTimer: software for measuring tic suppression
  80. Tourette syndrome research highlights from 2016
  81. Mapping movement, mood, motivation, and mentation in the subthalamic nucleus
  82. A Case of Apparent Upper-Body Freezing in Parkinsonism while Using a Wheelchair
  83. What creates the urge to tic in Tourette syndrome?
  84. Preliminary evidence that negative symptom severity relates to multilocus genetic profile for dopamine signaling capacity and D2 receptor binding in healthy controls and in schizophrenia
  85. Brain structure in pediatric Tourette syndrome
  86. VISIT-TS: A multimedia tool for population studies on tic disorders
  87. A picture is worth 1000 words: a new tool for Tourette studies
  88. Tourette syndrome research highlights 2015
  89. Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status
  90. Sweet Dopamine: Sucrose Preferences Relate Differentially to Striatal D 2 Receptor Binding and Age in Obesity
  91. Brain structure in pediatric Tourette syndrome
  92. When do tics turn into Tourette syndrome?
  93. Return of QuanDyn(TM)
  94. Designing MRI studies of children with neuropsychiatric disorders
  95. Machine learning "diagnosis" of Tourette syndrome by resting brain activity
  96. Correction: Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
  97. Safety of i.v. L-DOPA
  98. Automated training to hold still
  99. A review session can raise medical student scores on the psychiatry shelf exam
  100. Impact of a structured review session on medical student psychiatry subject examination performance
  101. Stand up for i.v. levodopa!
  102. Brain imaging in Tourette's, 2014-2015
  103. Safety of i.v. L-DOPA (preprint)
  104. Insulin, Central Dopamine D2 Receptors, and Monetary Reward Discounting in Obesity
  105. Tourette Syndrome research highlights 2014
  106. Brain dopamine pathways influence emotional eating
  107. Rapid quantitative pharmacodynamic imaging with Bayesian estimation
  108. Whole-brain blood flow correction in ASL
  109. Tourette Syndrome research highlights 2014
  110. Kids can suppress tics early on--if the price is right
  111. Levodopa effects on [11C]raclopride binding in the resting human brain
  112. Arterial spin labeling versus BOLD in direct challenge and drug-task interaction pharmacological fMRI
  113. F1000Research: Tics welcomes you to 21st century biomedical publishing
  114. Intro to special issue on Tourette syndrome
  115. Current anxiety disorder affects mood response to STN DBS in PD
  116. A revised method for measuring distraction by tactile stimulation
  117. Anatomical location in STN matters for DBS in Parkinson's
  118. Insulin, dopamine D2 receptors, and monetary reward discounting: A common pathway for food and drug addiction
  119. Developmental Changes in the Organization of Functional Connections between the Basal Ganglia and Cerebral Cortex
  120. Spatial Reorganization of Putaminal Dopamine D2-Like Receptors in Cranial and Hand Dystonia
  121. Levodopa-stimulated dopamine release in Tourette syndrome
  122. A within-subject comparison of seizure duration with etomidate and methohexital in electroconvulsive therapy
  123. Prolactin and fMRI response to SKF38393 in the baboon
  124. Automatic size and shape measurements of deep brain structures in Tourette syndrome
  125. Rapid quantitative pharmacodynamic imaging by a novel method: theory, simulation testing and proof of principle
  126. Towards objectively quantifying sensory hypersensitivity: a pilot study of the “Ariana effect”
  127. Olanzapine for psychosis in Parkinson disease
  128. Neurobiology and Functional Anatomy of Tic Disorders
  129. A comparison of D2 receptor specific binding in obese and normal-weight individuals using PET with (N-[11C]methyl)benperidol
  130. NMB PET outside the striatum
  131. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease
  132. Mood Response to Deep Brain Stimulation of the Subthalamic Nucleus in Parkinson's Disease
  133. A New (Old) Treatment Option for Depression in Parkinson's Disease
  134. Prospectively Determined Impact of Type 1 Diabetes on Brain Volume During Development
  135. Clinical Vignettes in Parkinson's Disease: A Collection of Unusual Medication-Induced Hallucinations, Delusions, and Compulsive Behaviours
  136. Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol) (TSfMRI)
  137. A Perfusion MRI Study of Emotional Valence and Arousal in Parkinson’s Disease
  138. Quantification of Indirect Pathway Inhibition by the Adenosine A2a Antagonist SYN115 in Parkinson Disease
  139. Tics
  140. Deep brain stimulation for Tourette syndrome
  141. Hippocampal Volumes in Youth With Type 1 Diabetes
  142. Neuroimaging in Baboons
  143. Cerebral Mitochondrial Metabolism in Early Parkinson's Disease
  144. Motor asymmetry and substantia nigra volume are related to spatial delayed response performance in Parkinson disease
  145. Psychiatric screening for DBS
  146. The Cognitive Correlates of Functional Status: A Review From the Committee on Research of the American Neuropsychiatric Association
  147. Regional Brain Volume Differences Associated With Hyperglycemia and Severe Hypoglycemia in Youth With Type 1 Diabetes
  148. Validity of large-deformation high dimensional brain mapping of the basal ganglia in adults with Tourette syndrome
  149. Intravenous levodopa administration in humans based on a two-compartment kinetic model
  150. The Value of Quantitative Electroencephalography in Clinical Psychiatry: A Report by the Committee on Research of the American Neuropsychiatric Association
  151. Repetitive and impulsive behaviors in treated Parkinson disease
  152. II.P5 Effects of Parkinson Disease (PD) laterality on spatial working memory performance
  153. Sex, Lies, and Neuroimaging
  154. Provisional diagnostic criteria for depression in Parkinson's disease: Report of an NINDS/NIMH Work Group
  155. Brain Stimulation in Psychiatric Treatment
  156. Blood Flow Imaging of the Brain: 50 Years Experience
  157. Levodopa Challenge Neuroimaging of Levodopa-Related Mood Fluctuations in Parkinson's Disease
  158. Pathophysiology of parkinsonism due to hydrocephalus
  159. Dopaminergic modulation of response inhibition: an fMRI study
  160. Cognitive-pharmacologic functional magnetic resonance imaging in tourette syndrome: a pilot study
  161. Atlas Template Images for Nonhuman Primate Neuroimaging: Baboon and Macaque
  162. Asymmetric regional cerebral blood flow in sedated baboons measured by positron emission tomography (PET)
  163. Rapid intravenous loading of levodopa for human research: clinical results
  164. Long term treatment and disease severity change brain responses to levodopa in Parkinson's disease
  165. A possible substrate for dopamine-related changes in mood and behavior: Prefrontal and limbic effects of a D3-preferring dopamine agonist
  166. Psychiatric Neuroimaging Research
  167. Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease
  168. Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease
  169. Template Images for Nonhuman Primate Neuroimaging: 2. Macaque
  170. Template Images for Nonhuman Primate Neuroimaging: 1. Baboon
  171. Dopa-Induced Blood Flow Responses in Nonhuman Primates
  172. Response to levodopa challenge in Tourette syndrome
  173. Neuropsychiatry of movement disorders
  174. On the efficiency of stereologic volumetry as commonly implemented for three-dimensional digital images
  175. Diminished regional cerebral blood flow response to vibration in patients with blepharospasm
  176. Altered thalamic response to levodopa in Parkinson’s patients with dopa-induced dyskinesias
  177. Putamen volume in idiopathic focal dystonia
  178. Preventing contractures in NMS and dystonia
  179. MPTP induces dystonia and parkinsonism: Clues to the pathophysiology of dystonia
  180. Baboon Basal Ganglia Stereotaxy Using Internal MRI Landmarks: Validation and Application to PET Imaging
  181. Personality disorder scores improve with effective pharmacotherapy of depression
  182. Stereological MRI volumetry of the frontal lobe
  183. A Metric for Testing the Accuracy of Cross-Modality Image Registration: Validation and Application
  184. The Dexamethasone Suppression Test for Diagnosing Depression in Stroke Patients
  185. Anosognosia for Depressive Signs
  186. Diagnosing Depression After Stroke
  187. Platelet Binding Characteristics Distinguish Placebo Responders from Nonresponders in Depression
  188. MRI volumetry of prefrontal cortex
  189. Hippocampal MR volumetry
  190. Severe Imipramine-Induced Myoclonus in a Patient with Psychotic Bipolar Depression, Catatonia, and Schizencephaly
  191. Subcortical brain anatomy in anorexia and bulimia
  192. Faculty of 1000 evaluation for Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome.
  193. TicTimer software for measuring tic suppression
  194. “But my department chair wants big-name journals”: Gentle steps to open publishing
  195. Software for web-based tic suppression training
  196. Tics
  197. Treatment of Parkinson’s disease psychosis
  198. Tourette syndrome research highlights from 2016